POSB270 Does Orphan Drug Status Confer Any Benefits for Products Undergoing HTA Appraisal By NICE in England?

Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.873
https://www.valueinhealthjournal.com/article/S1098-3015(21)02668-1/fulltext
Title : POSB270 Does Orphan Drug Status Confer Any Benefits for Products Undergoing HTA Appraisal By NICE in England?
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02668-1&doi=10.1016/j.jval.2021.11.873
First page :
Section Title :
Open access? : No
Section Order : 10405
Categories :
Tags :
Regions :
ViH Article Tags :